Travere Therapeutics, Inc.

Direct answer

Travere Therapeutics, Inc. is publicly traded on NASDAQ under the ticker TVTX.

Travere Therapeutics, Inc., a biopharmaceutical firm headquartered in San Diego, California, was founded in 2008 with a mission to discover, develop, commercialize, and deliver treatments for rare diseases. The company adopted its current name in November 2020, previously operating as Retrophin, Inc. Its current product offerings include Chenodal, an orally administered synthetic form of chenodeoxycholic acid, used...

Can you invest in Travere Therapeutics, Inc.?

Yes. Travere Therapeutics, Inc. trades publicly on NASDAQ as TVTX.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Travere Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.